Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma.

Fazio S, Linton MF
J Clin Endocrinol Metab. 2009 94 (4): 1081-3

PMID: 19349471 · PMCID: PMC2682471 · DOI:10.1210/jc.2009-0344

MeSH Terms (10)

Cardiovascular Diseases Carrier State Cholesterol, HDL Genetic Variation Humans Lipase Lipoproteins, HDL Liver Mutation Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: